Lv11
30 积分 2024-02-18 加入
Activity and Efficacy of Neoadjuvant Chemotherapy in Luminal-HER2 Negative Early Breast Cancer according to HER2 Score (Low vs Score 0): A Retrospective Study
6小时前
求助中
152 Reevaluation of HER2 Heterogeneous Expression in Breast Cancer by Using Multi-FFPE Blocks
6小时前
已完结
152 Reevaluation of HER2 Heterogeneous Expression in Breast Cancer by Using Multi-FFPE Blocks
2个月前
已完结
160 Occult Breast Carcinoma: Pathologic Features of an Uncommon Clinical Presentation in a Large Cohort
2个月前
已完结
173 Clinico-pathological Features and Immuno-histochemical Evaluation of TRPS1, GATA3, SOX10 and SATB2 in Metaplastic Breast Carcinoma with Osseous and Chondroid Differentiation
2个月前
已关闭
American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer
3个月前
已完结
Elacestrant (oral selective estrogen receptor degrader) Versus Standard Endocrine Therapy for Estrogen Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer: Results From the Randomized Phase III EMERALD Trial
3个月前
已完结
HER2-low breast cancers: Current insights and future directions
4个月前
已完结
HER2-low breast cancers: incidence, HER2 staining patterns, clinicopathologic features, MammaPrint and BluePrint genomic profiles
9个月前
已完结
HER2‐low heterogeneity between primary and paired recurrent/metastatic breast cancer: Implications in treatment and prognosis
11个月前
已完结
皖公网安备34019202002308
